These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29197371)

  • 1. Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.
    Eggly S; Hamel LM; Heath E; Manning MA; Albrecht TL; Barton E; Wojda M; Foster T; Carducci M; Lansey D; Wang T; Abdallah R; Abrahamian N; Kim S; Senft N; Penner LA
    BMC Cancer; 2017 Dec; 17(1):807. PubMed ID: 29197371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study.
    Eggly S; Senft N; Kim S; Heath EI; Jang H; Moore TF; Baidoun F; Manning MA; Penner LA; Albrecht TL; Carducci MA; Lansey D; Hamel LM
    Cancer Med; 2023 Apr; 12(7):8604-8613. PubMed ID: 36540051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disparity of words: racial differences in oncologist-patient communication about clinical trials.
    Eggly S; Barton E; Winckles A; Penner LA; Albrecht TL
    Health Expect; 2015 Oct; 18(5):1316-26. PubMed ID: 23910630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences.
    Bao Y; Fox SA; Escarce JJ
    Health Serv Res; 2007 Jun; 42(3 Pt 1):950-70. PubMed ID: 17489898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in Black men with prostate cancer: A literature review.
    Lillard JW; Moses KA; Mahal BA; George DJ
    Cancer; 2022 Nov; 128(21):3787-3795. PubMed ID: 36066378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonverbal synchrony as a behavioural marker of patient and physician race-related attitudes and a predictor of outcomes in oncology interactions: protocol for a secondary analysis of video-recorded cancer treatment discussions.
    Hamel LM; Moulder R; Albrecht TL; Boker S; Eggly S; Penner LA
    BMJ Open; 2018 Dec; 8(12):e023648. PubMed ID: 30518586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials.
    Braunstein JB; Sherber NS; Schulman SP; Ding EL; Powe NR
    Medicine (Baltimore); 2008 Jan; 87(1):1-9. PubMed ID: 18204365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Conceptual Framework for Understanding Shared Decision making Among African-American LGBT Patients and their Clinicians.
    Peek ME; Lopez FY; Williams HS; Xu LJ; McNulty MC; Acree ME; Schneider JA
    J Gen Intern Med; 2016 Jun; 31(6):677-87. PubMed ID: 27008649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
    Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
    J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients.
    Kaplan CP; Nápoles AM; Narine S; Gregorich S; Livaudais-Toman J; Nguyen T; Leykin Y; Roach M; Small EJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):443-448. PubMed ID: 26435199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial.
    Miranda J; Duan N; Sherbourne C; Schoenbaum M; Lagomasino I; Jackson-Triche M; Wells KB
    Health Serv Res; 2003 Apr; 38(2):613-30. PubMed ID: 12785564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American patients with cancer Talking About Clinical Trials (TACT) with oncologists during consultations: evaluating the efficacy of tailored health messages in a randomised controlled trial-the TACT study protocol.
    Brown RF; Davis R; Wilson Genderson M; Grant S; Cadet D; Lessard M; Alpert J; Ward J; Ginder G
    BMJ Open; 2016 Dec; 6(12):e012864. PubMed ID: 27986738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.
    Balakrishnan AS; Palmer NR; Fergus KB; Gaither TW; Baradaran N; Ndoye M; Breyer BN
    J Urol; 2019 Feb; 201(2):259-267. PubMed ID: 30218761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.
    Advani AS; Atkeson B; Brown CL; Peterson BL; Fish L; Johnson JL; Gockerman JP; Gautier M
    Cancer; 2003 Mar; 97(6):1499-506. PubMed ID: 12627515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between patient-provider communication and socio-cultural factors in prostate cancer patients: a cross-sectional evaluation of racial differences.
    Song L; Weaver MA; Chen RC; Bensen JT; Fontham E; Mohler JL; Mishel M; Godley PA; Sleath B
    Patient Educ Couns; 2014 Dec; 97(3):339-46. PubMed ID: 25224313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and pilot test of a physician-focused cancer clinical trials communication training intervention.
    Eggly S; Manning M; Senft N; Moore TF; Albrecht TL; Penner LA; Heath E; Carducci MA; Lansey DG; Hamel LM
    PEC Innov; 2022 Dec; 1():100012. PubMed ID: 37364021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial.
    Luque JS; Matthew OO; Jackson DR; Vargas MA; Austin T; Ali A; Kiros GE; Harris CM; Tawk R; Gwede CK; Wallace K; Jean-Pierre P
    Trials; 2022 Feb; 23(1):151. PubMed ID: 35168640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.